Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy

International Journal of Oncology

Volumn 31, Issue 4, 2007, Pages 793-802

  Denzinger, Stefan ^a   Stoehr, Robert ^a   Schwarz, Stephan ^a   Eichenseher, Nicole ^a   Brockhoff, Gero ^a   Obermann, Ellen C ^a   Knuechel, Ruth ^b   Blaszyk, Hagen ^c   Hartmann, Arndt ^a   Wild, Peter J ^d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bladder cancer; Fluorescence in situ hybridization; Histologically benign urothelium; SNP analysis; STK15

Indexed keywords

AURKA PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TUMOR MARKER; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; CASE CONTROL STUDY; CHROMOSOME ABERRATION; COMPARATIVE STUDY; CYSTECTOMY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL RATE; TUMOR RECURRENCE; UROTHELIUM;

AGED; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CYSTECTOMY; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 35848939403     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.4.793     Document Type: Article

References (25)

1. Lengauer C, Kinzler KW and Vogelstein B: Genetic instability in colorectal cancers. Nature 386: 623-627, 1997.
2. Sen S: Aneuploidy and cancer. Curr Opin Oncol 12: 82-88, 2000.
3. Cahill DP, Kinzler KW, Vogelstein B and Lengauer C: Genetic instability and darwinian selection in tumours. Trends Cell Biol 9: 57-60, 1999. (Pubitemid 30009468)
4. Zhou H, Kuang J, Zhong L, et al: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193, 1998.
5. Miyoshi Y, Iwao K, Egawa C and Noguchi S: Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 92: 370-373, 2001.
6. Grady WM: Genomic instability and colon cancer. Cancer Metastasis Rev 23: 11-27, 2004.
7. Mhawech-Fauceglia P, Fischer G, Beck A, Cheney RT and Herrmann FR: Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up. Eur J Surg Oncol 32: 439-444, 2006.
8. Sen S, Zhou H, Zhang RD, et al: Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94: 1320-1329, 2002.
9. Fraizer GC, Diaz MF, Lee IL, Grossman HB and Sen S: Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol 25: 1631-1639, 2004.
10. Ewart-Toland A, Briassouli P, De Koning JP, et al: Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34: 403-412, 2003. (Pubitemid 36935333)
11. Ewart-Toland A, Dai Q, Gao YT, Nagase H, et al: Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 26: 1368-1373, 2005. (Pubitemid 41417879)
12. Simon R, Atefy R, Wagner U, et al: HER-2 and TOP2A coamplification in urinary bladder cancer. Int J Cancer 107: 764-772, 2003. (Pubitemid 37339730)
13. Eble JN, Sauter G, Epstein JI and Sesterhenn I: Pathology and genetics of tumours of the urinary system and male genital organs. In: World Health Organization Classification of Tumours. Eble JN (ed.). IARC Press, Lyon, pp143-145, 2004.
14. Harnden P, Mahmood N and Southgate J: Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 353: 974-977, 1999. (Pubitemid 29132607)
15. De Vere White RW, Deitch AD, Tesluk H, et al: Prognostic significance of DNA ploidy in Ta/T1 bladder cancer: a South-West Oncology Group Study. Urol Oncol 2: 27-34, 1996. (Pubitemid 26292002)
16. Richter J, Beffa L, Wagner U, et al: Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 153: 1615-1621, 1998. (Pubitemid 28509919)
17. Richter J, Wagner U, Schraml P, et al: Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 59: 5687-5691, 1999.
18. Wilting SM, Snijders PJ, Meijer GA, et al: Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 209: 220-230, 2006.
19. Nessling M, Richter K, Schwaenen C, et al: Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res 65: 439-447, 2005.
20. Katayama H, Sasai K, Kawai H, et al: Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36: 55-62, 2004. (Pubitemid 38056208)
21. Metwalli AR and Kamat AM: Controversial issues and optimal management of stage T1G3 bladder cancer. Expert Rev Anticancer Ther 6: 1283-1294, 2006.
22. Grossman HB, Tangen CM, Cordon-Cardo C, et al: Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study. Oncol Rep 16: 807-810, 2006.
23. Hernandez S, Lopez-Knowles E, Lloreta J, et al: FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis. Clin Cancer Res 11: 5444-5450, 2005. (Pubitemid 41060820)
24. Hammerschmied CG, Stoehr R, Walter B, Wieland WF, Hartmann A, Blaszyk H and Denzinger S: Role of STK15 Phe31Ile polymorphism in renal cell carcinoma. Oncol Rep 17: 3-7, 2007.
25. Gu J, Gong Y, Huang M, Lu C, Spitz MR and Wu X: Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. Carcinogenesis, August 21, Epup, doi:10.1093/carcin/bgl149.